Developing new biopharmaceutical products for infectious diseases
Preclinical Services for Biopharmaceutical Product Development
['FUNDING_OTHER'] · INTERNATIONAL AIDS VACCINE INITIATIVE · NIH-10934767
This study is all about helping scientists create new medicines, like antibodies and proteins, to treat infections, so that patients can eventually benefit from these innovative therapies in the future.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INTERNATIONAL AIDS VACCINE INITIATIVE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10934767 on ClinicalTrials.gov |
What this research studies
This research focuses on providing essential services to support the preclinical development of biopharmaceutical products, including monoclonal antibodies, recombinant proteins, and nucleic acid-based vectors like small interfering RNA. The program aims to advance translational research by offering product development planning, assay development, and regulatory support to ensure effective treatments for infectious diseases. Patients may benefit from innovative therapies that emerge from this preclinical work, which is crucial for bringing new treatments to clinical trials.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals affected by infectious diseases who may be eligible for new biopharmaceutical therapies.
Not a fit: Patients with non-infectious diseases or those not eligible for biopharmaceutical interventions may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for infectious diseases.
How similar studies have performed: Previous research in biopharmaceutical development has shown success in creating effective treatments, indicating that this approach is promising.
Where this research is happening
NEW YORK, UNITED STATES
- INTERNATIONAL AIDS VACCINE INITIATIVE — NEW YORK, UNITED STATES (ACTIVE)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Diseases Research, Infectious Diseases / Laboratory